Amgen Inc. (AMGN)
Amgen Inc. reported revenue of $36.75B for the fiscal year ended Dec 31, 2025, up 10.0% from $33.42B the year before. Net income was $7.71B, a net margin of 21.0% (prior year: $4.09B). At the end of that fiscal year the company reported total assets of $90.59B and shareholders' equity of $8.66B.
Revenue
$36.75B
+10.0% vs prior year
Net income
$7.71B
Net margin 21.0%
Diluted EPS
$14.23
USD per share
Total assets
$90.59B
At Dec 31, 2025
Equity
$8.66B
At Dec 31, 2025
Shares outstanding
541M
As of Jul 30, 2026
Explore Amgen Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Aug 5, 2026
- 10-QFiled May 1, 2026
- 10-KFiled Feb 13, 2026
- 10-QFiled Nov 5, 2025
- 10-QFiled Aug 6, 2025
- 10-QFiled May 2, 2025
Source: SEC EDGAR XBRL company facts for CIK 318154 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.